TherapeuticsMD Reports Closing of Enrollment in REJOICE Trial for TX-004HR

By: via Benzinga
TherapeuticsMD Inc. (NYSE: TXMD), an innovative women's healthcare company, today announced that the Company has completed patient ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.